Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug in Early Alzheimer's Disease Lead Investing
Heritage Mining Congratulates Neighbouring Treasury Metals Inc. on Combination Transaction with Frank Giustra Backed Deal Base Metals Investing
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024 Lead Investing
Teck to Present at the BofA Securities 2024 Global Metals, Mining and Steel Conference Platinum Investing
Altiplano Reports Q1 2024 Operational Results at Farellon with 2.29% Copper Recovered in March Base Metals Investing
Aston Bay and American West Metals Announce New Copper Targets at the Storm Copper Project, Canada Base Metals Investing
Cascadia To Participate in the Gentile Mining Investor Forum and Michael Gentile Mining & Metals European Roadshow
